Autotransfusion Devices Market Analysis and Forecast to 2031: By Product Type (Autotransfusion Systems, Consumables & Accessories), Application (Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries,

Autotransfusion Devices Market Analysis and Forecast to 2031: By Product Type (Autotransfusion Systems, Consumables & Accessories), Application (Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries, Others), End User (Hospitals, Specialty Clinics & Others), and Region

The global autotransfusion devices market was valued at USD 255 million in 2021 and it is anticipated to grow further till USD 419.3 million by 2031, at a CAGR of 5.1% during the forecast period.

To collect and re-infuse the patient's blood, autotransfusion devices are frequently employed. The use of autologous blood transfusions to prevent infections brought on by allogeneic blood transfusions is made possible by these systems, which play a significant part in cell salvage approaches. These tools are used in invasive procedures for the heart, the joints, the nervous system, obstetrics, and gynecology. Systems can be divided into intraoperative systems, post-operative systems, and dual-mode systems based on how usable they are.

Global Autotransfusion Devices Market Scope and Report Structure

Market Trends and Drivers

Some of the major drivers anticipated to propel market expansion during the projected period include an increase in surgical operations, an increase in the number of surgical cases, and an increase in the number of liver or other organ transplant surgeries. Additionally, it is predicted that the market would expand due to the growing older population in the world as well as increased demand for cardiac devices. The rise in blood illnesses, the number of trauma and accident cases, and technological advancements all contribute to the growth of the blood transfusion device.

Market Restraints and Challenges

The high cost associated with autotransfusion systems coupled with risk associated with autotransfusion market is anticipated to hinder the growth of the market.

Global Autotransfusion Devices Market Segmental Overview

The global autotransfusion devices market is segmented into product type, application, end user, and region.

Global Autotransfusion Devices Market by Product Type

Based on the product type, it is segmented into autotransfusion systems, and consumables & accessories. The autotransfusion system segment is anticipated to dominate the market during the forecast period. The rising adoption of autotransfusion systems in developed and developing countries owing to their efficiency in blood transfusion is anticipated to boost the growth of the segment.

Global Autotransfusion Devices Market by Application

Based on the application, it is segmented into cardiovascular surgeries, orthopedic surgeries, neurological surgeries, obstetrics & gynecological surgeries, and others. The cardiovascular surgeries segment is anticipated to dominate the market during the forecast period. The increasing number of cardiovascular procedures, like coronary artery bypass grafting, implantable cardioverter-defibrillator & pacemaker implantations, heart transplantation, valve replacement surgeries, and others is anticipated to boost the growth of this segment.

Global Autotransfusion Devices Market by End User

Based on the end user, it is segmented into hospitals, specialty clinics & others. The hospital segment is expected to dominate the market during the forecast period. The increasing number of cardiovascular and obstetrics & gynecological surgeries carried out in hospitals is expected to boost the growth of the market during the forecast period.

Geographical Analysis of the Global Autotransfusion Devices Market

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. The increasing use of autologous blood transfusion in major cardiovascular & orthopedic surgeries coupled with the presence of developed healthcare infrastructure is boosting the growth of the market.

Major Players in the Global Autotransfusion Devices Market

The key players studied in the report are LivaNova PLC (U.K.), Medtronic (Ireland), Haematonics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), BD (Becton, Dickinson, and Company) (U.S.), Beijing Jingjing Medical Equipment Co., Ltd. (China), and ProCell Surgical Inc. (U.S.) among others.

COVID-19 Impact

The expansion of the autotransfusion devices market was adversely affected by the COVID-19 pandemic epidemic. It demonstrated a significant drop in revenue as a result of fewer surgical procedures being conducted. These tools are primarily utilized during heavy blood loss procedures, like orthopedic and heart surgery. The need for autologous blood transfusion equipment has decreased along with the decline in surgical procedures.

For instance, the COVID-19 pandemic was said to have caused a 48% decrease in the total number of surgical procedures carried out in the United States, according to data published by the American Medical Association. However, the number of surgical procedures rebounded to normal levels once the pandemic limitations were lifted.

Recent Developments

November 2021, Fresenius SE & Co. KGaA announced a collaboration with Omnicell, Inc., with aim to offer innovative new pharmacy technology to the U.S. hospitals and health systems.

June 2020, ProCell Surgical Inc., announced the launch of ProCell, its first Medical Devices designed to effectively automate the manual and outdated activity of surgical sponge-blood recovery for intraoperative autotransfusion.

December 2019, Hemonetics Corporation launched the Next Generation Safe Trace Tx Transfusion Management Software in North America. The newly released software provides an enhanced user experience and superior operational workflow, thereby enabling extended care quality.

Frequently Asked Questions

Q1. How big is the Autotransfusion Devices market?

Ans. The global Autotransfusion Devices market size was USD 255 million in 2021 and it is anticipated to grow further till USD 419.3 billion by 2031, at a CAGR of 5.1% from 2022 to 2031.

Q2. What is the Autotransfusion Devices market growth rate?

Ans. The growth rate of the Autotransfusion Devices market is 5.1%.

Q3. Which region holds a major market share for the Autotransfusion Devices market?

Ans. North America holds a major market share of the Autotransfusion Devices market in 2021.

Q4. Which segment accounted for the largest Autotransfusion Devices market share?

Ans. By end user, the hospitals segment accounted for the largest Autotransfusion Devices market share.

Q5. Who are the key players in the Autotransfusion Devices market?

Ans. The global Autotransfusion Devices market report includes players such as LivaNova PLC (U.K.), Medtronic (Ireland), Haematonics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), BD (Becton, Dickinson, and Company) (U.S.), Beijing Jingjing Medical Equipment Co., Ltd. (China), and ProCell Surgical Inc. (U.S.) among others.

Q6. What are the factors driving the Autotransfusion Devices market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of Autotransfusion Devices market players?

Ans. The key growth strategies of Autotransfusion Devices market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Autotransfusion Devices market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Autotransfusion Devices market during the forecast period.